$0.070
(0%)
|
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 13 November 2026 at 10:14am | ||||
RHINOMED LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (13-Nov) $11,471,000 (1,037th) |
Close (30-Jun) $0.070 |
Volume (30-Jun) 0 |
Shortsold (8-Jan) 4,400 (0.00%) (473rd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.04 |
Rhinomed half year results - 31 December 2021
RNO released this announcement to the ASX on 23 February 2022, 13:09. The announcement is not marked as price sensitive, and is 18 page(s) in length and 13.59MB in size.
You can view all announcements from RNO and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from RNO | |
|---|---|
| Change in substantial holding WG | 18 May 2023, 9:23 |
| App 3Y MJ | 4 May 2023, 10:56 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 28 April 2023, 9:19 |
| Rhinomed half year results - 31 December 2021 | 23 February 2022, 13:09 |
| Half Yearly Report and Accounts | 23 February 2022, 13:06 |
| R & D refund | 16 February 2022, 8:06 |
| Corporate Governance Statement | 10 February 2022, 10:50 |
If you were already registered, log in here.
If you were already registered, log in here.